article · Journal of Robotic Surgery
CKD patients are susceptible to pneumoperitoneum-induced renal injury; comparative outcomes of robotic versus laparoscopic inguinal hernia repair are unknown. Retrospective propensity score-matched cohort using TriNetX (184 HCOs; 2015-2026). CKD adults undergoing robotic or laparoscopic inguinal hernia repair were matched 1:1 on 61 covariates (1,693 per arm at 1 month; 1,659 at 6 months). Primary outcomes were AKI and MACE; secondary outcomes were metabolic acidosis, urinary retention, hyperkalemia, and post-operative eGFR and creatinine. Cox regression, Kaplan-Meier, and competing-risk CIF were used, with E-values for unmeasured confounding. At 1 month, robotic repair had higher AKI (5.0% vs. 2.9%; HR 1.74, 95% CI 1.22-2.47; p = 0.002) and MACE (2.5% vs. 1.4%; HR 1.84; p = 0.017). At 6 months, AKI persisted (HR 1.41; p = 0.002) and urinary retention emerged (HR 1.33; p = 0.039); MACE (p = 0.112) and acidosis (p = 0.199) did not. New-onset hyperkalemia was lower with robotic (HR 0.58; p = 0.045). eGFR MDRD declined less at 1 month (Δ - 1.28 vs. - 3.21; p = 0.049); 6-month creatinine was lower (p = 0.013). CIF (deaths 1.5% vs. 1.9%) confirmed AKI; KM overstated 6-month incidence by 1.1-1.9 points. 1-month AKI E-value 2.87 (CI 1.74). Robotic inguinal hernia repair in CKD was associated with higher AKI and early MACE in the all-events analysis, but the incident AKI signal was borderline and post-operative laboratory renal function favored the robotic arm. This discordance may reflect differential ascertainment at robotic-predominant academic centers. These hypothesis-generating findings do not establish a renal safety advantage for either approach; prospective validation with KDIGO-defined AKI endpoints is required.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.1007/s11701-026-03782-y
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.